The University of Kansas Cancer Center has announced $10 million in gifts and grants from four individuals and four foundations in support of a collaboration with Children's Mercy Hospital to transform Kansas City into a global pediatric research innovation hub.
The funding will establish four endowed chair appointments at Children's Mercy designed help eliminate childhood diseases around the world. The positions, which will have joint KU faculty appointments, are focused on genomics, health outcomes, hematological malignancies, and immunotherapy and are a key consideration for the National Cancer Institute as it evaluates whether to approve the center as a Comprehensive Cancer Center.
Recruitment is underway for the positions, which include the DeBruce Foundation Endowed Chair in Immunotherapy, funded by Paul DeBruce and the DeBruce Foundation with a matching gift from the Hall Family Foundation; the Stanley H. Durwood Foundation Endowed Chair in Health Outcomes, funded by a grant from the Stanley H. Durwood Foundation, trustee Charles J. Egan, Jr., and a matching gift from Donald J. Hall; the Roberta D. Harding and William F. Bradley, Jr. Endowed Chair in Genomic Research, funded by Roberta D. Harding and William F. Bradley Jr. with a matching gift from Donald J. Hall; the Schutte/Speas Endowed Chair in Hematologic Malignancies, funded by the Victor E. and Caroline E. Schutte Foundation, David W. Frantze and Bank of America, N.A., co-trustees; and the Victor E. Speas Foundation, Bank of America, N.A., trustee.
"For our Children's Research Institute, this is a game-changer, allowing us to offer stellar recruitment packages to attract the best and brightest pediatric research scientists to Kansas City," said Tom Curran, Children's Mercy's chief scientific officer and executive director of its Children's Research Institute. "It's a privilege to collaborate with KU Cancer Center in this important effort."